Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
27.20
-1.55 (-5.39%)
At close: Apr 28, 2026, 4:00 PM EDT
27.36
+0.16 (0.59%)
After-hours: Apr 28, 2026, 4:17 PM EDT
Tectonic Therapeutic Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
60
Market Cap
510.72M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rigel Pharmaceuticals | 294.28M |
| Sutro Biopharma | 102.48M |
| Fulcrum Therapeutics | 80.00M |
| Verastem | 30.91M |
| Altimmune | 41.00K |
| Lyell Immunopharma | 36.00K |
TECX News
- 5 days ago - Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors - GlobeNewsWire
- 6 weeks ago - Tectonic Therapeutic Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Tectonic Therapeutic Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic Transcript: KOL event - Transcripts
- 2 months ago - Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026 - GlobeNewsWire
- 5 months ago - Tectonic Therapeutic Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts